Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon.
D000042:Absorption; D000328:Adult; D000368:Aged; D000372:Agglutination Tests; D000818:Animals; D000918:Antibody Specificity; D000937:Antigen-Antibody Reactions; D002850:Chromatography, Gel; D003429:Cross Reactions; D003601:Cytotoxicity Tests, Immunologic; D004802:Eosinophilia / Q000276:immunology; D004804:Eosinophils / Q000276:immunology*; D006689:Hodgkin Disease / Q000276:immunology; D006801:Humans; D007106:Immune Sera / Q000302:isolation & purification*; D007122:Immunoelectrophoresis; D007070:Immunoglobulin A / Q000032:analysis; D007074:Immunoglobulin G / Q000032:analysis; D007075:Immunoglobulin M / Q000032:analysis; D007136:Immunoglobulins / Q000032:analysis; D007951:Leukemia, Myeloid / Q000276:immunology; D008297:Male; D051379:Mice / Q000276:immunology; D009504:Neutrophils / Q000276:immunology; D011817:Rabbits / Q000276:immunology
D007106:Immune Sera; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins